headernewbase
Home About Us Technology Product & Services News & Events Contact Us
 
  2007 2008 2009 2010 2011

News

Presentations

Announcements


 

2011 Announcements

  • February 2011 - Vivo Biosiences and ITT Labs have signed a
    R&D agreement to develop new chemotherapy analysis/diagnostic
    applications by integrating micro-tumor bioassay and pharmacogenomics
    testing platforms. At present ITT labs provide 5FU-toxicity testing services
    for cancer patients (CLIA facility). Vivo has submitted a NIH-SBIR proposal
    for real-time chemosensitivity biossay system.


2010 Announcements

  • March 2010 - Vivo Biosciences is happy to announce that it has signed
    a co-marketing agreement with Southern Research. It will promote/market
    Vivo's new 3D HuBiogel assay platform to enhance its oncology drug
    screening and preclinical pharmaceutical services. High-value human
    3D mini-tumors (monotypic & heterotypic) and angiogenesis assay systems
    offer an advanced/robust DD pipeline. They are cost-effective and
    complementary to HTS assays and animal xenograft models.

2009 Announcements

  • September 2009 - Birmingham, AL – September 28, 2009 – Dr. Raj K. Singh, President and Chief Scientific Officer of Vivo Biosciences, will be presenting
    a talk at the upcoming Drug Discovery Partnerships: Filling the Pipeline meeting in Boston, MA on Friday, May 30, 2009. Additionally, Vivo Biosciences will have an exhibition booth at the meeting which is organized by Opal Events. The title
    of Dr. Singh’s talk is, “New In Vitro Preclinical Drug Discovery Platform Collaborations: Addressing Needs with 3D Mini-Tumor Bioassay
    Systems.” PDF

  • July 2009 - Vivo Biosciences is pleased to announce a new SBIR grant awarded by NCI to develop novel dignostic antibodies for prostate cancer patients

  • May 2009 - Vivo is selected by NIH-ACT to present its 3D HuBiogel technology at Life Sciences VC Forum, San Jose, CA on June 25, 2009. This one-day event, organised by LARTA, highlights NIH-SBIR supported innovative technologies and VC funding opprtunities.

  • May 2009 - Vivo is happy to announce that it will be exhibiting at the 2009 International BIO conference in Atlanta, Georgia (Booth# 2933, May 18-21). Please stop by to explore R&D collaboration and partnership opportunities in the area of oncology, drug toxicity and patient therapy profiling.
2008 Announcements

2007 Announcements

2006 Announcements

2005 Announcements

 
Home / About Us / Technology / Products & Services / News & Events / Contact Us
© 2012 All Rights Reserved. Vivo Biosciences, Inc. Office 1+205-930-0001
Vivobiotech.com